Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Interim results presented at EULAR from phase I trial of IDEC-131

June 9, 1999

Widely used antipsychotic drug under study for potential in RA

June 9, 1999

Novel rheumatic disease treatment strategy discussed at EULAR congress

June 9, 1999

Novel marine metabolite has antiinflammatory properties

June 9, 1999

Antifibroproliferative agents emerge from FibroGen/Zeneca collaboration

June 8, 1999

Small-molecule inhibitors of proinflammatory cytokines developed at Boehringer Ingelheim

June 8, 1999

D2E7 plus methotrexate: a safe and effective treatment for rheumatoid arthritis

June 8, 1999

Merck Frosst investigates alternatives to conventional NSAIDs

June 8, 1999

EULAR meeting highlights: overview of clinical experience with Reumacon

June 8, 1999

In vitro studies shed light on the mechanism of action of triptolide

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...